Chung, Sang-Hyuk2020-03-102020-03-102015-08Copyright 2015 Trends in Endocrinology & Metabolism. This is a post-print version of a published paper that is available at: https://www.sciencedirect.com/science/article/pii/S1043276015001137?via%3Dihub. Recommended citation: Chung, Sang-Hyuk. "Targeting female hormone receptors as cervical cancer therapy." Trends in Endocrinology & Metabolism 26, no. 8 (2015): 399-401. DOI: 10.1016/j.tem.2015.06.004. This item has been deposited in accordance with publisher copyright and licensing terms and with the author's permission.https://hdl.handle.net/10657/5921While preventive methods for cervical cancer are effective, available therapies for advanced cervical cancers are ineffective. New experimental evidence points to weaknesses of prior studies and provides fresh molecular insights on the opposing roles of ER? and PR, which may be translated into valuable treatment for a subset of cervical cancers.en-UShuman papillomavirus (HPV)estrogen receptor ?ER?progesterone receptorPRcervical cancerhormonal therapyArticle